CTLA4 and chronic myelogenous leukemia, BCR-ABL1 positive: Depleting K3 with a CTLA-4–binding RNA aptamer linked to a K3-small interfering RNA in CTLA-4+ LSCs induces disease remission and prolongs the survival of mice with CML [49].